Pancreatic Cancer Research

ResearcherFukushima Medical UniversityActive in the last 2 years

Hiroki Irie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4805-6244; OpenAlex author ID A5102798568. Sources: OpenAlex.

Their work

Papers
11
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 3 papers · 2023: 2 papers · 2024: none · 2025: 2 papers

Papers 11

  1. Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. Co-author DOI 10.21873/anticanres.17798↗
  2. Impact of COVID-19 pandemic on unresectable pancreatic cancer: a regional cohort study in Japan. Co-author DOI 10.5387/fms.24-00011↗
  3. Clinical benefit of subsequent chemotherapy after drug-induced interstitial lung disease in pancreatic cancer patients: a multicenter retrospective study from … Co-author DOI 10.1186/s12885-023-10781-x↗
  4. A multicenter comparative study of endoscopic ultrasound-guided fine-needle biopsy using a Franseen needle versus conventional endoscopic ultrasound-guided fin… Co-author DOI 10.5946/ce.2022.019↗
  5. The Complement C3a-C3a Receptor Axis Regulates Epithelial-to-Mesenchymal Transition by Activating the ERK Pathway in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.15587↗
  6. Intracellular C3 Modulates EMT via the Akt/Smad Pathway in Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.16081↗
  7. Drug treatment for chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer. Co-author DOI 10.5387/fms.2021-32↗
  8. Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients. Co-author DOI 10.1186/s12885-021-09069-9↗
  9. Interstitial lung disease in advanced pancreatic ductal adenocarcinoma patients treated with gemcitabine and nab-paclitaxel combination therapy: a retrospectiv… Co-author DOI 10.1007/s00280-019-03983-3↗
  10. Evaluation of inflammation-based markers for predicting the prognosis of unresectable pancreatic ductal adenocarcinoma treated with chemotherapy. Co-author DOI 10.3892/mco.2018.1696↗
  11. Endoscopic ultrasound-guided fine needle aspiration for pancreatic cancer. Co-author DOI 10.5387/fms.2018-14↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mitsuru Sugimoto · 11 shared papers, 2018–2025 · strength 1.54
  2. Hiromasa Ohira · 11 shared papers, 2018–2025 · strength 1.54
  3. Rei Suzuki · 10 shared papers, 2018–2025 · strength 1.31
  4. Tadayuki J. Takagi · 10 shared papers, 2018–2025 · strength 1.31
  5. Hiroyuki Asama · 7 shared papers, 2018–2025 · strength 1.05
  6. Yuichi Waragai · 2 shared papers, 2025 · strength 0.45
  7. Hiroshi Shimizu · 2 shared papers, 2025 · strength 0.45
  8. Kentaro Sato · 2 shared papers, 2025 · strength 0.45
  9. Rei Suzuki · 1 shared paper, 2025 · strength 0.23
  10. Rei Ohira · 1 shared paper, 2025 · strength 0.23
  11. Shigeru Marubashi · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.